Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

from Talking Precision Medicine · host Genialis

In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of genetic medicines. Michelle shares her zigzag journey from scientist to executive, how her team is tackling the biggest bottlenecks in gene therapy, and why AI has become essential in designing safer, more effective treatments. ⁠⁠TPM E51 highlights >⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode 51 links:Michelle Chen on LinkedInForm Bio

Episode metadata supplied by the publisher feed · Published Nov 13, 2025

Embed this episode

Attribution link and audio player

Ready to play

Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

0:00 36:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Precision Medicine?

This episode is 36 minutes long.

When was this Talking Precision Medicine episode published?

This episode was published on November 13, 2025.

Can I download this Talking Precision Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!